TrialCPT: pharmacometrics & systems pharmacology2022

Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib (FGF401) drug treatment.

Mélanie Wilbaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.